Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS): A randomized controlled trial

JAMA

Volumn 276, Issue 10, 1996, Pages 785-791

  Borhani, Nemat O ^a,b   Mercuri, Michele ^c   Borhani, Patricia A ^a,b   Buckalew, Vardaman M ^c   Canossa Terris, Maria ^d   Carr, Albert A ^e   Kappagoda, Tissa ^a   Rocco, Michael V ^c   Schnaper, Harold W ^f   Sowers, James R ^g   Bond, M Gene ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d Florida Heart Research Institute   (United States)

^e Circulatory Disease Center   (United States)

^f Scientific Application Co Inc   (United States)

^g WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCHLOROTHIAZIDE; ISRADIPINE;

ADULT; AGED; ANGINA PECTORIS; ANTIHYPERTENSIVE THERAPY; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE;

EID: 9544225173     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.10.785     Document Type: Article

References (39)

1. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
2. Chobanian AV. The 1989 Corcoran lecture: adaptive and maladaptive responses of the arterial wall to hypertension. Hypertension. 1990;15:666-674.
3. MacMahon SW, Cutler JA, Furberg CD, Payne GH. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis. 1986;29(suppl 1):99-118.
4. Cutler JA, MacMahon SW, Furberg CD. Controlled clinical trials of drug treatment for hypertension. Hypertension. 1989;13(suppl 1):I-36-I-44.
5. Collins R, Peto R, MacMahon S. Blood pressure, stroke, and coronary heart disease, part II: short term reduction in blood pressure, overview of randomized drug trials in their epidemiological context. Lancet. 1990;335:827-838.
6. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of SHEP. JAMA 1991;265:3255-3264.
7. Dahlof B, Lindholm L, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients With Hypertension (STOP-Hypertension). Lancet. 1991;338:1281-1285.
8. MRC Working Party. MRC trial of treatment of hypertension in older adults: principal results. BMJ. 1992;304:405-412.
9. Kirkendall WM. Comparative assessment of firstline agents for treatment of hypertension. Am J Med. 1988;84(suppl 3B):32-41.
10. Weinstein DB, Heider JG. Antiatherogenic properties of calcium antagonists. Am J Cardiol. 1987; 59:163B-172B.
11. Chobanian AV. Effects of calcium antagonists and other antihypertensive drugs on atherosclerosis. J Hypertens Suppl. 1987;5(suppl 4):43-48.
12. Weinstein DB, Heider JG. Protective action of calcium antagonists in atherosclerosis and experimental vascular injury. Am J Hypertens. 1989;2:205-212.
13. Bond MG, Purvis C, Mercuri M. Antiatherogenic properties of calcium antagonists. J Cardiovasc Pharmacol. 1991;17(suppl 4):87-93.
14. Furberg CD, Adams HP, Applegate WB, et al. Effect of lovastatin on early atherosclerosis and cardiovascular events. Circulation. 1994;90:1679-1687.
15. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C, and the ARIC Investigators. Carotid atherosclerosis measured by B-mode ultrasound in populations. Am J Epidemiol. 1991;134:250-256.
16. Salonen JT, Seppänen K, Rauramaa R, Salonen R. Risk factors for carotid artherosclerosis: the Kuoplo Ischemic Heart Disease Risk Factor Study. Ann Med. 1989;21:227-229.
17. Furberg CD, Byington RP, Borhani NO. Design features: Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). Am J Med. 1989;86 (suppl 4A):37-39.
18. Bond MG, Wilmoth SK, Enevold GL, Strickland HL. Detection and monitoring of asymptomatic atherosclerosis in clinical trials. Am J Med. 1989;86(suppl 4A):33-36.
19. Furberg CD, Borhani NO, Byington RP, Gibbons ME, Sowers JE. Calcium antagonists and atherosclerosis. Am J Hypertension. 1993;6:24S-29S.
20. Borhani NO, Miller ST, Brugger SB, et al. MIDAS: hypertension and atherosclerosis, a trial of the effect of antihypertensive drug treatment on atherosclerosis. J Cardiovasc Pharmacol. 1992;19(suppl 3):16-20.
21. Mercuri M, Bond MG, Nichols FT, et al. Baseline reproducibility of B-mode ultrasound imaging measurements of carotid intima media thickness: the Multicenter Isradipine Diuretic Atherosclerosis study (MIDAS). J Cardiovasc Diagn Proc. 1993;11:241-256.
22. Borhani NO, Bond MG, Sowers JR, et al. The MIDAS: a study of the antiatherogenic properties of isradipine in hypertensive patients. J Cardiovasc Pharmacol. 1991;18(suppl 3):15-19.
23. Insull W Jr, Bond MG, Wilmoth S, Fishel J, Herson J. Ultrasound lesions of the carotid artery and risk factors in man. In: Glagov S, Newman WP III, Schaffer SA, eds. Pathobiology of the Human Atherosclerotic Plaque. New York, NY: Springer-Verlag NY Inc; 1990:662-669.
24. Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics. 2nd ed. East Norwalk, Conn: Appleton & Lange; 1994:133-134.
25. Laird NM, Ware JH. Random effects models for longitudinal data. Biometrics. 1982;38:963-974.
26. SAS Institute Inc. The MIXED procedure. In: SAS Technical Report P-229, SAS/STAT Software: Changes and Enhancements, Release 6.07. Cary, NC: SAS Institute Inc; 1992:21.
27. Applegate WB, Byington RP, on behalf of MIDAS Research Group. The MIDAS: design features and baseline data. Am J Hypertens. 1991;4:114S-117S.
28. Riley WA, Barnes RW, Applegate WB, et al. Reproducibility of noninvasive ultrasound measurement of carotid atherosclerosis: the Asymptomatic Carotid Artery Plaque Study (ACAPS). Stroke. 1992; 23:1062-1068.
29. Mercuri M, Tang R, Espeland M, Byington R, Bond MG, Borhani N. Does isradipine vasodilate common carotid arteries? the MIDAS database. J Hypertens. 1994;12(suppl 3):S134. Abstract.
30. Polak JF, O'Leary DH, Kronmal RA, et al. Sonographic evaluation of carotid artery atherosclerosis in the elderly. Radiology. 1993;188:363-370.
31. Zanchetti A. Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) Trial and the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens Suppl. 1995;13(suppl 4):S35-S39.
32. Psaty BM, Heckbert SR, Kopsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995;274:620-625.
33. Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose related increase in mortality in patients with coronary heart disease. Circulation. 1995;92:1326-1331.
34. Ruzicka M, Leenen FHH. Relevance of intermittent increase in sympathetic activity for adverse outcome on short-acting calcium antagonists. In: Lasagh JH, Brenner BM, eds. Hypertensive Pathophysiology, Diagnosis and Management. 2nd ed. New York, NY: Raven Press; 1995:2815-2825.
35. Waters D. Proischemic complications of dihydropyridine calcium channel blockers. Circulation. 1991;84:2598-2600.
36. Van den Berg EK, Dehmer GJ. Acute hemodynamic effects of intravenous isradipine. Am J Cardiol. 1988;61:1102-1105.
37. Davis BR, Cutler JA, Gordon DJ, et al, for the ALLHAT Research Group. Rationale and design of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Am J Hypertens. 1996;9:342-360.
38. Staessen J, Bert P, Bulpitt C, et al, for the SYST-EUR Trial. Nitrendipine in older patients with isolated systolic hypertension. J Hum Hypertens. 1993;7:265-271.
39. Dahlof B, Hansson L, Lindholm LH, et al. STOP-Hypertension-2: a prospective intervention trial of 'newer' versus 'older' treatment alternatives in old patients with hypertension. Blood Press. 1993;2:136-141.